Cas:39573-31-4 3-ethyl-1H-benzimidazole-2-thione manufacturer & supplier

We serve Chemical Name:3-ethyl-1H-benzimidazole-2-thione CAS:39573-31-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-ethyl-1H-benzimidazole-2-thione

Chemical Name:3-ethyl-1H-benzimidazole-2-thione
CAS.NO:39573-31-4
Synonyms:1-Aethyl-1,3-dihydro-benzimidazol-2-thion;1-ethyl-1,3-dihydro-benzoimidazole-2-thione;F1076-0015;1-ethyl-1H-benzimidazole-2-thiol;1-Ethyl-1H-benzoimidazole-2-thiol;1-ethylbenzimidazole-2-thiol
Molecular Formula:C9H10N2S
Molecular Weight:178.25400
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:283.9ºC at 760mmHg
Density:1.27g/cm3
Index of Refraction:1.686
PSA:56.62000
Exact Mass:178.05600
LogP:2.34490

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Aethyl-1,3-dihydro-benzimidazol-2-thion chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-ethylbenzimidazole-2-thiol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-ethyl-1,3-dihydro-benzoimidazole-2-thione Use and application,1-ethyl-1H-benzimidazole-2-thiol technical grade,usp/ep/jp grade.


Related News: After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. 6-Bromo-4-methyl-1H-indazole-3-carbaldehyde manufacturers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. 2-Thiazole sulfenamide,4,5-dimethyl- suppliers As we expand our offering into the US and beyond, NOVA aims to become the go-to partner for pharma and biotech companies for in silico clinical trial support. I am delighted to welcome Grégoire to the Novadiscovery team and look forward to working closely with him.” 3-[3,5-Bis(trifluoromethyl)phenyl]propanal vendor & factory Meanwhile, EMA’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending marketing authorization for Moderna’s Covid-19 vaccine, now known as Spikevax, to include adolescents 12 years of age and older. ,As we expand our offering into the US and beyond, NOVA aims to become the go-to partner for pharma and biotech companies for in silico clinical trial support. I am delighted to welcome Grégoire to the Novadiscovery team and look forward to working closely with him.”